Identification of C-mannosylation in a receptor tyrosine kinase AXL

Kento Mori1, Takehiro Suzuki2, Urara Waki1

  • 1Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Kanagawa 223-8522, Japan.

Glycobiology
|December 11, 2024
PubMed

Insights

C-mannosylation, a unique protein modification, was confirmed on AXL receptor tyrosine kinase. This modification impacts AXL

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • C-mannosylation is a rare post-translational modification where mannose is attached to tryptophan residues in proteins.
  • The biological roles of C-mannosylation remain largely unelucidated.
  • AXL receptor tyrosine kinase is frequently overexpressed in various cancers, promoting tumor progression, invasion, drug resistance, and vasculogenic mimicry.

Purpose of the Study:

  • To confirm C-mannosylation at Tryptophan 320 (Trp320) of AXL.
  • To investigate the functional impact of AXL C-mannosylation on cancer cell behavior, specifically vasculogenic mimicry.
  • To explore whether C-mannosylation affects AXL's downstream signaling pathways.

Main Methods:

  • Mass spectrometry was employed to detect and confirm C-mannosylation of recombinant AXL.
  • CRISPR/Cas9 gene editing was used to generate AXL-deficient breast cancer cells (MDA-MB-231).
  • Re-expression of wild-type and C-mannosylation-deficient AXL mutants was performed in these engineered cells.

Main Results:

  • C-mannosylation at Trp320 of AXL was experimentally confirmed using mass spectrometry analysis of purified recombinant AXL.
  • Re-expression of C-mannosylation-deficient AXL led to a significant reduction in vasculogenic mimicry formation in MDA-MB-231 cells.
  • Phosphorylation levels of AKT, a key downstream signaling molecule, were similar between cells expressing wild-type AXL and C-mannosylation-deficient AXL.

Conclusions:

  • This study provides the first evidence of C-mannosylation occurring on a receptor tyrosine kinase, specifically AXL.
  • AXL C-mannosylation appears to play a role in regulating AXL-mediated vasculogenic mimicry formation, independent of canonical AKT signaling.
  • These findings suggest a novel mechanism by which C-mannosylation influences receptor tyrosine kinase function in cancer progression.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K